Warren Buffett's Dexter Shoes Acquisition Details
Berkshire Hathaway acquired Dexter Shoe Company in 1993 for approximately 433 million dollars in a stock transaction, exchanging Berkshire Class B shares for all outstanding Dexter shares. Warren Buffett later described the deal as a major mistake, citing ongoing losses and intense competition from low-cost overseas manufacturers. The acquisition is widely cited in Berkshire Hathaway annual reports and shareholder letters as a cautionary lesson in durable goods manufacturing.
The Dexter transaction was part of Buffett's broader strategy to buy high-quality businesses with durable competitive advantages, but the footwear sector proved structurally challenging. Berkshire Hathaway sold off the Dexter brand and remaining assets over time after years of operating losses. The episode is frequently referenced in value investing literature as an example of competitive moat erosion in commodity-like manufacturing.
Dexter Shoes Business and Market Position
Dexter Shoe Company was founded in 1958 and grew into one of the largest U.S. manufacturers of leather and athletic footwear before the acquisition. The company operated plants in Maine and produced private-label and branded shoes for major retailers across North America. At its peak, Dexter was a significant employer in the U.S. shoe manufacturing sector.
By the early 1990s, Dexter faced mounting pressure from imported shoes, particularly from China, Vietnam, and other low-cost producers. The company's manufacturing costs remained higher than competitors, and margins compressed steadily. Warren Buffett acknowledged that the competitive dynamics of the global shoe industry were harder to defend than anticipated, leading to sustained losses for Berkshire Hathaway after the deal.
Berkshire Hathaway's Investment Lessons from Dexter Shoes
Warren Buffett has repeatedly used the Dexter Shoes investment in Berkshire Hathaway shareholder letters to illustrate the importance of understanding industry structure and cost advantages. He emphasized that durable competitive moats, such as brand strength, scale, or unique resources, are essential for long-term profitability in manufacturing. The Dexter experience reinforced Berkshire's preference for businesses with pricing power and limited exposure to low-cost global competition.
Despite the Dexter loss, Berkshire Hathaway's overall investment portfolio has delivered exceptional long-term returns, with the company's market capitalization growing from roughly 433 million dollars at the time of the Dexter deal to over 900 billion dollars in recent years. The Dexter case remains a key case study in value investing education, alongside other notable investments in companies like See's Candies and Apple. Investors can review detailed historical performance and strategic insights on the Berkshire Hathaway official investor relations page and through curated financial analysis on Forbes.